The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Risk score for outcome after allogeneic hematopoietic stem cell transplantation: A Retrospective Analysis
Open accessAbstract
BACKGROUND: It was investigated whether the European Group for Blood and Marrow Transplantation risk score, previously established for chronic myeloid leukemia, could be used to predict outcome after allogeneic hematopoietic stem cell transplantation (HSCT) for hematological disease in general. METHODS: Age of patient, disease stage, time interval from diagnosis to transplant, donor type, and donor‐recipient sex combination were used to establish a score from 0 to 7 points. Its validity was tested in 56,505 patients, 33,113 (58%) male, 23,392 female, median age 33 years (range, 0.5‐77 years), with an allogeneic HSCT for a hematological disorder between 1980 and 2005. RESULTS: Survival probability at 5 years decreased from 71% (95% confidence interval [CI], 69%‐73%) for risk score 0 for the whole cohort (75%, 95% CI, 72%‐78% for the most recent time cohort) to 24% (95% CI, 21%‐27% for risk score 6 and 7; 25%, 95% CI, 22%‐29% most recent cohort). Transplant‐related mortality increased from 15% (95% CI, 14%‐17%) for risk score 0 (11%, 95% CI, 9%‐13%, most recent cohort) to 47% with risk score 6 and 7 (95% CI, 44%‐50%) for the whole cohort (45%, 95% CI, 42%‐48%, most recent cohort). The risk score was predictive in all disease categories, over all time periods, and was not altered by transplant techniques. CONCLUSIONS: Five well‐defined pretransplant patient and donor characteristics give a reasonable risk estimate of allogeneic HSCT. This risk score can provide a basis for the decision between transplant and nontransplant strategies. Cancer 2009. © 2009 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040296 · Cited by 23,020
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00010 · Cited by 17,796
Vandenbroucke, J. P., von Elm, E., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., Egger, M., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040297 · Cited by 8,613
Hematopoietic Stem-Cell Transplantation
Copelan, E. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052638 · Cited by 2,522
Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia
Schlenk, R. F., Döhner, K., Krauter, J., Fröhling, S., Corbacioglu, A., Bullinger, L., Habdank, M., Späth, D., Morgan, M., Benner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa074306 · Cited by 1,628
Cited by
Döhner, H., Estey, E. H., Amadori, S., Appelbaum, F. R., Büchner, T., Burnett, A. K., Dombret, H., Fenaux, P., Grimwade, D., Larson, R. A., et al. (2010) · Blood · doi:10.1182/blood-2009-07-235358 · Cited by 3,373
Self-citationTherapeutic Advances in Acute Myeloid Leukemia
Burnett, A., Wetzler, M., & Löwenberg, B. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.1820 · Cited by 787
Khwaja, A., Bjorkholm, M., Gale, R. E., Levine, R. L., Jordan, C. T., Ehninger, G., Bloomfield, C. D., Estey, E., Burnett, A., Cornelissen, J. J., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.10 · Cited by 592
Kollman, C., Spellman, S. R., Zhang, M.-J., Hassebroek, A., Anasetti, C., Antin, J. H., Champlin, R. E., Confer, D. L., DiPersio, J. F., Fernandez-Viña, M., et al. (2016) · Blood · doi:10.1182/blood-2015-08-663823 · Cited by 365
Who is the best donor for a related HLA haplotype-mismatched transplant?
Wang, Y., Chang, Y.-J., Xu, L.-P., Liu, K.-Y., Liu, D.-H., Zhang, X.-H., Chen, H., Han, W., Chen, Y.-H., Wang, F.-R., et al. (2014) · Blood · doi:10.1182/blood-2014-03-563130 · Cited by 344
Metadata
- Authors
- Gratwohl, A., Stern, M., Brand, R., Apperley, J., Baldomero, H., de Witte, T., Dini, G., Rocha, V., Passweg, J., Sureda, A., Tichelli, A., Niederwieser, D., & for the European Group for Blood and Marrow Transplantation and the European Leukemia Net
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2009-10-05
- Volume
- 115
- Issue
- 20
- Pages
- 4715-4726
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2137489389
- Cited by
- 379
- References
- 5
- FWCI
- 18.23
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Risk score for outcome after allogeneic hematopoietic stem cell transplantation: A Retrospective Analysis. https://app.cochat.ai/papers/10.1002/cncr.24531
- The paper
- Gratwohl, A., Stern, M., Brand, R., Apperley, J., Baldomero, H., de Witte, T., Dini, G., Rocha, V., Passweg, J., Sureda, A., Tichelli, A., Niederwieser, D., & for the European Group for Blood and Marrow Transplantation and the European Leukemia Net. (2009). Risk score for outcome after allogeneic hematopoietic stem cell transplantation: A Retrospective Analysis. Cancer. https://doi.org/10.1002/cncr.24531
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
